Discontinued Operations (Tables)

3 Months Ended

Mar. 31, 2015

Discontinued Operations.

Components of discontinued operations

	Three Months Ended March 31
(in millions)	2015			2014
Net Sales
Developed markets generics pharmaceuticals and animal health businesses	$	256		$	489
AbbVie	—			—
Total	$	256		$	489
Earnings Before Tax
Developed markets generics pharmaceuticals and animal health businesses	$	25		$	82
AbbVie	—			—
Total	$	25		$	82
Income Tax Expense (Benefit)
Developed markets generics pharmaceuticals and animal health businesses	$	12		$	(33	)
AbbVie	(13		)	(36		)
Total	$	(1	)	$	(69	)
Net Earnings
Developed markets generics pharmaceuticals and animal health businesses	$	13		$	115
AbbVie	13			36
Total	$	26		$	151

Summary of the assets and liabilities held for sale

(in millions)	March 31, 2015		December 31, 2014
Trade receivables, net	$	91	$	498
Total inventories	54		254
Prepaid expenses, deferred income taxes, and other receivables	28		140
Current assets held for disposition	173		892
Net property and equipment	2		125
Intangible assets, net of amortization	—		804
Goodwill	—		950
Deferred income taxes and other assets	1		55
Non-current assets held for disposition	3		1,934
Total assets held for disposition	$	176	$	2,826
Trade accounts payable	$	286	$	423
Salaries, wages, commissions and other accrued liabilities	15		257
Current liabilities held for disposition	301		680
Post-employment obligations, deferred income taxes and other long-term liabilities	—		108
Total liabilities held for disposition	$	301	$	788